Noteworthy new and updated reports from the Congressional Research Service that Congress has withheld from online public distribution include the following.
Cybersecurity: Authoritative Reports and Resources, September 20, 2013
Reaching the Debt Limit: Background and Potential Effects on Government Operations, September 19, 2013
Across-the-Board Rescissions in Appropriations Acts: Overview and Recent Practices, September 20, 2013
Private Health Plans Under the ACA: In Brief, September 19, 2013
Patient Protection and Affordable Care Act (ACA): Resources for Frequently Asked Questions, September 19, 2013
Medicare Financing, September 19, 2013
The State of Campaign Finance Policy: Recent Developments and Issues for Congress, September 20, 2013
The National Voter Registration Act of 1993: History, Implementation, and Effects, September 18, 2013
U.S. Natural Gas Exports: New Opportunities, Uncertain Outcomes, September 17, 2013
America COMPETES Acts: FY2008-FY2013 Funding Tables, September 20, 2013
The DHS S&T Directorate: Selected Issues for Congress, September 17, 2013
U.S. Special Operations Forces (SOF): Background and Issues for Congress, September 18, 2013
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”
The United States’ biosecurity governance system is structurally incapable of detecting and responding to certain classes of threats. U.S. biosecurity tools have not kept pace with technological advancements or a changing threat landscape.